Will Express Scripts Pay for Ozempic in 2026? Coverage Guide

Getting your Ozempic is a prescription medication containing semaglutide, primarily used to treat type 2 diabetes and recently approved for chronic weight management covered by insurance can feel like a lottery. You fill out the forms, wait weeks, and then get rejected. If you are on an Express Scripts plan (now part of Cigna), you are likely wondering if your specific policy will pick up the tab. The short answer is: it depends entirely on whether you have Type 2 Diabetes or if you are using it strictly for weight loss.

As of August 2026, the landscape has shifted significantly since the drug’s initial launch. While many people assume big pharma means big coverage, the reality is more nuanced. This guide breaks down exactly how Express Scripts handles Ozempic claims, what documentation you need, and how to navigate the approval process without losing your mind.

The Two Faces of Ozempic Coverage

To understand why your claim might be denied, you first need to distinguish between the two FDA-approved indications for semaglutide. These are treated as completely separate products by most insurance companies, including those managed by Cigna.

• Type 2 Diabetes: Prescribed as Ozempic. This is generally easier to get covered because it treats a chronic metabolic condition with clear clinical guidelines.
• Chronic Weight Management: Prescribed as Wegovy. This is much harder to get covered because insurers often view weight loss medications as "elective" or require extensive proof that other methods failed.

If your doctor prescribes Ozempic specifically for weight loss without a diagnosis of Type 2 Diabetes, there is a high chance your Express Scripts plan will deny it unless you meet strict Body Mass Index (BMI) criteria. Conversely, if you have Type 2 Diabetes, even if weight loss is a side benefit, coverage is more standard.

How Express Scripts Processes Your Claim

Express Scripts operates as a Pharmacy Benefit Manager (PBM). This means they don't just pay for the drug; they negotiate prices with manufacturers and decide which drugs are on your plan's formulary. When you submit a claim for Ozempic, the system checks three things:

1. Formulary Status: Is Ozempic on your specific plan's list of preferred drugs? In 2026, most major plans have moved Ozempic to Tier 3 or Tier 4, meaning higher out-of-pocket costs.
2. Prior Authorization (PA): Do you have medical evidence proving you need this specific drug? For diabetes, this usually means showing that metformin or other cheaper insulin options didn't work well enough.
3. Step Therapy: Have you tried cheaper alternatives? Insurers often require you to fail on at least one or two other glucose-lowering agents before approving semaglutide.

Here is a practical tip: check your plan documents for the term "Preferred Formulary." If Ozempic is not listed there, expect a copay that could range from $150 to over $300 per month, depending on your deductible status.

Meeting the Criteria: What Insurers Actually Look For

It is not just about having a prescription. It is about meeting the clinical thresholds set by Cigna and Express Scripts. For patients seeking coverage for Type 2 Diabetes, the typical requirements include:

• A confirmed diagnosis of Type 2 Diabetes.
• An HbA1c level above 7% despite treatment with other oral hypoglycemics.
• Documentation that you have tried and failed at least one other class of diabetes medication (like sulfonylureas or DPP-4 inhibitors).

For weight management under the Wegovy label, the bar is higher. You typically need a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition (such as hypertension or sleep apnea). Additionally, you must provide records showing you have attempted lifestyle modifications (diet and exercise) for at least six months without significant success.

Navigating Prior Authorization: A Step-by-Step Guide

Don't let the paperwork scare you. Most denials happen because of missing information, not because the drug isn't worth covering. Here is how to handle the process efficiently:

1. Ask Your Doctor for a Letter of Medical Necessity: This letter should explicitly state why Ozempic is necessary and why cheaper alternatives failed. Generic letters get denied; specific ones get approved.
2. Submit Early: Do not wait until your last vial is empty. Submit the Prior Authorization request at least 10-14 days before you run out of medication. Processing times for Express Scripts can vary from 7 to 21 days.
3. Check Status Online: Use the Cigna member portal or call the number on your card. Ask specifically if the PA is "pending review" or "under step therapy verification."
4. Appeal Immediately if Denied: If denied, ask for the reason code. Common codes include "Not Medically Necessary" or "Step Therapy Not Met." An appeal with additional lab results often reverses these decisions within 30 days.

Pro tip: If your primary care provider is busy, ask them to fax your recent HbA1c reports directly to the pharmacy benefits team. Having hard data attached to the PA form speeds up the decision significantly.

Cost-Saving Strategies and Alternatives

Even with insurance, Ozempic can be expensive. If your out-of-pocket cost exceeds $200 per month, consider these strategies:

• Manufacturer Savings Cards: Novo Nordisk offers savings cards that can reduce copays to as low as $25-$50 for eligible commercial plans. Check if your Express Scripts plan qualifies.
• Switching to Compounded Semaglutide: While the FDA has tightened regulations on compounded versions, some pharmacies still offer legal compounded semaglutide for patients who cannot afford brand-name drugs. Verify the pharmacy's license carefully.
• Generic Substitutes: Currently, no true generic exists for Ozempic, but biosimilars are entering the market in late 2026. Keep an eye on updates regarding biosimilar approvals which may lower costs.
• Health Savings Accounts (HSA): If you have an HSA, paying cash for Ozempic is tax-deductible. This can effectively lower your net cost compared to using insurance with high deductibles.

Many patients find that mixing strategies works best. For example, using the manufacturer card for the first few months while appealing a denial, or switching to a lower dose if clinically appropriate to stay within a lower tier.

Frequently Asked Questions